Master
Media Component
Content
Our portfolio of technologies reflects the work of visionary scientists and physicians’ intent on finding solutions to today’s greatest healthcare needs and disease challenges. We welcome the opportunity to partner with forward-thinking businesses to bring these commercially ready technologies to market.
Heading
Featured Technology
Terms
Item Definition
Potent, selective, small molecule inhibitors of steroid receptor co-activators (SRC) can be developed into potential therapeutics for different types of cancers. Our proprietary SI-12 compound is simpler and less costly to manufacture, distribute, store, and administer to patients. Learn more.
